Exact Sciences Corporation
EXAS
$101.25
$0.050.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.08B | 2.94B | 2.83B | 2.76B | 2.69B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.08B | 2.94B | 2.83B | 2.76B | 2.69B |
| Cost of Revenue | 1.01B | 956.17M | 918.49M | 903.45M | 874.50M |
| Gross Profit | 2.08B | 1.98B | 1.91B | 1.86B | 1.82B |
| SG&A Expenses | 1.84B | 1.78B | 1.73B | 1.69B | 1.67B |
| Depreciation & Amortization | -71.06M | -71.06M | -71.06M | -71.06M | -68.85M |
| Other Operating Expenses | -- | -- | -- | -- | -2.03M |
| Total Operating Expenses | 3.20B | 3.08B | 3.01B | 2.95B | 2.92B |
| Operating Income | -121.49M | -138.98M | -176.89M | -191.79M | -227.22M |
| Income Before Tax | -994.77M | -1.01B | -1.03B | -1.04B | -210.57M |
| Income Tax Expenses | -8.19M | -9.22M | -8.89M | -7.30M | 3.47M |
| Earnings from Continuing Operations | -986.58 | -1.01K | -1.02K | -1.03K | -214.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -986.58M | -1.01B | -1.02B | -1.03B | -214.04M |
| EBIT | -121.49M | -138.98M | -176.89M | -191.79M | -227.22M |
| EBITDA | 96.88M | 78.28M | 38.09M | 23.07M | -11.34M |
| EPS Basic | -5.32 | -5.42 | -5.50 | -5.56 | -1.17 |
| Normalized Basic EPS | -0.39 | -0.47 | -0.60 | -0.65 | -0.71 |
| EPS Diluted | -5.33 | -5.43 | -5.51 | -5.57 | -1.17 |
| Normalized Diluted EPS | -0.39 | -0.47 | -0.60 | -0.65 | -0.71 |
| Average Basic Shares Outstanding | 750.29M | 745.82M | 741.23M | 736.77M | 732.57M |
| Average Diluted Shares Outstanding | 750.29M | 745.82M | 741.23M | 736.77M | 732.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |